The Effect of Repeated Simulation in Developing Social Justice Advocacy Attitudes and Skills on Nursing Student

January 28, 2025 updated by: Esin Ateş, Ege University
It is a randomized controlled experimental and single-blind study with a pretest-posttest control group design.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It is a randomized controlled experimental and single-blind study with a pretest-posttest control group design, planned to examine the effect of repeated simulation (standard patient simulation) on improving nursing students' social justice advocacy attitudes and skills.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Izmir, Turkey, 35100
        • Ege University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteering to participate in the research Being a 4th year undergraduate nursing student Having completed the theoretical education for vocational courses

Exclusion Criteria:

  • Being a foreign national (due to Turkish speaking/understanding problem)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
They will perform repetitive simulation (standard patient simulation according to scenarios) with the students in the experimental group.
Behavioral: experimental group

Experimental Group-Repetitive Simulation

  • First simulation application; It will be done in groups of four with a total of 5 groups (n=20). In each scenario, one student in the group will participate in the role of nurse and three other students will participate as audience. Four students in each group will take part in a standard patient simulation consisting of four different scenarios.
  • Second simulation application; It will be carried out with the students in the experimental group about 3-4 weeks after the first simulation. Each student will use one new scenario alone in the second simulation.
Other: control group
A single simulation will be applied to the control group (standard patient simulation according to scenarios).
Behavioral: experimental group

Experimental Group-Repetitive Simulation

  • First simulation application; It will be done in groups of four with a total of 5 groups (n=20). In each scenario, one student in the group will participate in the role of nurse and three other students will participate as audience. Four students in each group will take part in a standard patient simulation consisting of four different scenarios.
  • Second simulation application; It will be carried out with the students in the experimental group about 3-4 weeks after the first simulation. Each student will use one new scenario alone in the second simulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Repeated simulation
Time Frame: four weeks

Repeated simulation is effective in developing nursing students' social justice advocacy attitudes and skills.

Students' social justice advocacy attitudes will be measured with the "Social Justice Advocacy Scale". The scale is a 7-point Likert-type scale. 1 means "Absolutely Not True" and 7 means "Absolutely True". The minimum score is 41 and the maximum score is 287 from the scale; it is stated that as the scores obtained from the scale increase, social justice advocacy skills also increase.

Students' advocacy skills will be measured with the "Social Justice Advocacy Skills Assessment Guide". The scoring in the guide was as follows: "Not Done = 0, insufficient performance = 1 and sufficient performance = 2.". The minimum score received from the guide is 0 and the maximum score is 48; as the total score received from the guide increases, the students' advocacy application skill levels are considered to be higher.
four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ege University

Investigators

  • Study Chair: Süheyla Özsoy, Prof, suheyla.ozsoy@ege.edu.tr

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2023

Primary Completion (Actual)

August 30, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

July 21, 2023

First Submitted That Met QC Criteria

July 21, 2023

First Posted (Actual)

July 28, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 28, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Ege Uni-NF-11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe